tiprankstipranks
Apogee Therapeutics expands board of directors with appointment of Bollinger
PremiumThe FlyApogee Therapeutics expands board of directors with appointment of Bollinger
2M ago
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
PremiumPress Releases
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
2M ago
Apogee Therapeutics Starts Phase 2 Trial for Atopic Dermatitis Drug
PremiumCompany Announcements
Apogee Therapeutics Starts Phase 2 Trial for Atopic Dermatitis Drug
2M ago
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
PremiumPress ReleasesApogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
4M ago
Apogee announces first participants dosed in Phase 1 trial of APG808
PremiumThe Fly
Apogee announces first participants dosed in Phase 1 trial of APG808
4M ago
Four new option listings on March 20th
PremiumThe Fly
Four new option listings on March 20th
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100